Literature DB >> 22889703

Sudden cardiac death in non-ischemic dilated cardiomyopathy: a critical appraisal of existing and potential risk stratification tools.

Emmanuel Koutalas1, Emmanuel Kanoupakis, Panos Vardas.   

Abstract

Non ischemic dilated cardiomyopathy poses a significant risk of malignant ventricular arrhythmias and subsequent sudden cardiac death. The pathologic and electrophysiological substrate implicated to arrhythmogenesis has been quite adequately defined over the last decades and multiple forms of myocardial fibrosis - diffuse, patchy or gross scarring - are being studied regarding their arrhythmogenic potential. Moreover, the recent demonstration and continuous expansion of knowledge regarding causative genes in dilated cardiomyopathy open a new chapter in the field of diagnosis and prognosis of these patients. Numerous noninvasive and invasive methods have been used to stratify patients according to sudden cardiac death level of risk. Severely reduced left ventricular systolic myocardial function, expressed mostly by left ventricular ejection function, NYHA functional class, syncope and invasive electrophysiological study with programmed electrical stimulation have been incorporated into international guidelines, though leaving significant proportions of primary prevention patients out of stratification schemes. Electrocardiographic markers, signal-averaged ECG, heart rate variability, heart rate turbulence, baroreflex sensitivity, heart rate recovery and T-wave alternans have given conflicting results in non ischemic dilated cardiomyopathy. During the last decade, cardiac magnetic resonance, especially with gadolinium enhancement, has made a step forward in defining the fibrotic substrate of such patients. Prospective studies have given promising results, demonstrating correlation between late gadolinium enhancement and ventricular arrhythmogenesis. Identification of patients with genetically caused dilated cardiomyopathy prone to sudden cardiac death and large prospective trials investigating cardiac magnetic resonance and its prognostic potential may be able to establish a new era in stratification schemes.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22889703     DOI: 10.1016/j.ijcard.2012.07.014

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

Review 1.  Utility of late gadolinium enhancement in pediatric cardiac MRI.

Authors:  Maryam Etesami; Robert C Gilkeson; Prabhakar Rajiah
Journal:  Pediatr Radiol       Date:  2015-12-30

2.  Impact of psychological distress on cardiovagal reactivation after a speech task.

Authors:  A P Koutnik; M A Sanchez-Gonzalez; R W May; R M Hughes; F D Fincham
Journal:  J Hum Hypertens       Date:  2013-12-12       Impact factor: 3.012

3.  The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI.

Authors:  Cemile Ayşe Görmeli; Zeynep Maraş Özdemir; Ayşegül Sağır Kahraman; Jülide Yağmur; Ramazan Özdemir; Cemil Çolak
Journal:  Radiol Med       Date:  2016-10-27       Impact factor: 3.469

Review 4.  Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.

Authors:  Marco Giuseppe Del Buono; Rocco A Montone; Massimiliano Camilli; Salvatore Carbone; Jagat Narula; Carl J Lavie; Giampaolo Niccoli; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2021-09-28       Impact factor: 24.094

5.  Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing?

Authors:  Alexandra Sousa; Paulo Canedo; Manuel Campelo; Brenda Moura; Sérgio Leite; Márcia Baixia; Adriana Belo; Francisco Rocha-Gonçalves; José Carlos Machado; José Silva-Cardoso; Elisabete Martins
Journal:  Cardiol Res Pract       Date:  2019-04-24       Impact factor: 1.866

Review 6.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

7.  MAGGIC Risk Model Predicts Adverse Events and Left Ventricular Remodeling in Non-Ischemic Dilated Cardiomyopathy.

Authors:  Yang Dong; Dongfei Wang; Jialan Lv; Zhicheng Pan; Rui Xu; Jie Ding; Xiao Cui; Xudong Xie; Xiaogang Guo
Journal:  Int J Gen Med       Date:  2020-12-10

Review 8.  Stratification of the risk of sudden death in nonischemic heart failure.

Authors:  Maurício Pimentel; Leandro Ioschpe Zimerman; Luis Eduardo Rohde
Journal:  Arq Bras Cardiol       Date:  2014-08-29       Impact factor: 2.000

9.  Predictors of Total Mortality and Serious Arrhythmic Events in Non-Ischemic Heart Failure Patients: The Role of Galectin-3.

Authors:  Adriano Nunes Kochi; Mauricio Pimentel; Michael Andrades; Tiago Zimerman; Leandro Ioschpe Zimerman; Luis Eduardo Rohde
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

10.  Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy.

Authors:  Zhi-Hua Zhang; Fan-Qi Meng; Xiao-Feng Hou; Zhi-Yong Qian; Yao Wang; Yuan-Hao Qiu; Zhe-Yu Jiang; An-Jie Du; Chao-Tong Qin; Jian-Gang Zou
Journal:  Indian Heart J       Date:  2020-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.